PE20140917A1 - Sintesis de derivados de 2-carboxamida-cicloamino-urea - Google Patents

Sintesis de derivados de 2-carboxamida-cicloamino-urea

Info

Publication number
PE20140917A1
PE20140917A1 PE2013002003A PE2013002003A PE20140917A1 PE 20140917 A1 PE20140917 A1 PE 20140917A1 PE 2013002003 A PE2013002003 A PE 2013002003A PE 2013002003 A PE2013002003 A PE 2013002003A PE 20140917 A1 PE20140917 A1 PE 20140917A1
Authority
PE
Peru
Prior art keywords
formula
compound
solvent
producing
contact
Prior art date
Application number
PE2013002003A
Other languages
English (en)
Spanish (es)
Inventor
Bernhard Erb
Isabelle Sylvie Gallou
Florian Karl Kleinbeck
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45787206&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20140917(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PE20140917A1 publication Critical patent/PE20140917A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26Radicals substituted by halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PE2013002003A 2011-03-03 2012-03-01 Sintesis de derivados de 2-carboxamida-cicloamino-urea PE20140917A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161448774P 2011-03-03 2011-03-03

Publications (1)

Publication Number Publication Date
PE20140917A1 true PE20140917A1 (es) 2014-08-14

Family

ID=45787206

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2013002003A PE20140917A1 (es) 2011-03-03 2012-03-01 Sintesis de derivados de 2-carboxamida-cicloamino-urea

Country Status (33)

Country Link
US (3) US9650373B2 (https=)
EP (1) EP2681192B1 (https=)
JP (1) JP6022485B2 (https=)
KR (1) KR101851421B1 (https=)
CN (2) CN103402982B (https=)
AR (2) AR088714A1 (https=)
AU (1) AU2012222346B2 (https=)
BR (1) BR112013021882A2 (https=)
CA (1) CA2828509C (https=)
CL (1) CL2013002521A1 (https=)
CO (1) CO6751286A2 (https=)
DK (1) DK2681192T3 (https=)
EA (4) EA025381B1 (https=)
EC (1) ECSP13012914A (https=)
ES (1) ES2663717T3 (https=)
GT (1) GT201300211A (https=)
HU (1) HUE036319T2 (https=)
IL (1) IL228023A (https=)
MA (1) MA34982B1 (https=)
MX (2) MX351740B (https=)
MY (1) MY163214A (https=)
NO (1) NO2681192T3 (https=)
PE (1) PE20140917A1 (https=)
PH (1) PH12013501796A1 (https=)
PL (1) PL2681192T3 (https=)
PT (1) PT2681192T (https=)
SG (1) SG192793A1 (https=)
SI (1) SI2681192T1 (https=)
TN (1) TN2013000354A1 (https=)
TW (2) TWI597279B (https=)
UA (1) UA112539C2 (https=)
WO (1) WO2012117071A1 (https=)
ZA (1) ZA201306174B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA112539C2 (uk) * 2011-03-03 2016-09-26 Новартіс Аг Спосіб одержання похідних 2-карбоксамідциклоаміносечовини
WO2016077832A2 (en) * 2014-11-14 2016-05-19 Gemphire Therapeutics Inc. PROCESSES AND INTERMEDIATES FOR PREPARING α,ω-DICARBOXYLIC ACID-TERMINATED DIALKANE ETHERS
EP3612171A4 (en) 2017-04-18 2020-10-21 Gemphire Therapeutics Inc. GEMCABENE, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, COMPOSITIONS THEREOF AND PROCEDURES FOR THE USE OF THE SAME
CN112961090A (zh) * 2019-12-13 2021-06-15 武汉九州钰民医药科技有限公司 合成Alpelisib的关键中间体及其制备方法
CN111057051A (zh) * 2019-12-16 2020-04-24 武汉九州钰民医药科技有限公司 PI3K抑制剂Alpelisib的新合成方法
CN110964005A (zh) * 2019-12-16 2020-04-07 武汉九州钰民医药科技有限公司 一种Alpelisib的制备工艺
KR20220125753A (ko) 2021-03-05 2022-09-14 배성륭 기능성 풍력 발전시스템
CN119462487A (zh) * 2023-08-08 2025-02-18 重庆博腾制药科技股份有限公司 一种阿培利司中间体4-甲基吡啶类化合物的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3534056A (en) * 1967-03-02 1970-10-13 Pennwalt Corp Fluoro-alkyl pyridines and their preparation
UA60365C2 (uk) 1998-06-04 2003-10-15 Пфайзер Продактс Інк. Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
DE60023926T2 (de) 1999-09-10 2006-07-20 Merck & Co., Inc. Tyrosin kinase inhibitoren
TW200519106A (en) * 2003-05-02 2005-06-16 Novartis Ag Organic compounds
CA2639910A1 (en) * 2006-01-25 2007-08-02 Synta Pharmaceuticals Corp. Thiazole and thiadiazole compounds for inflammation and immune-related uses
TWI428091B (zh) 2007-10-23 2014-03-01 Du Pont 殺真菌劑混合物
EP2240475B1 (en) * 2007-12-20 2013-09-25 Novartis AG Thiazole derivatives used as pi 3 kinase inhibitors
WO2009080649A2 (en) * 2007-12-21 2009-07-02 Telefonaktiebolaget Lm Ericsson (Publ) Improvements in or relating to wireless mobility
UA104147C2 (uk) * 2008-09-10 2014-01-10 Новартис Аг Похідна піролідиндикарбонової кислоти та її застосування у лікуванні проліферативних захворювань
UA112539C2 (uk) * 2011-03-03 2016-09-26 Новартіс Аг Спосіб одержання похідних 2-карбоксамідциклоаміносечовини

Also Published As

Publication number Publication date
PH12013501796A1 (en) 2022-10-26
CA2828509C (en) 2018-11-20
DK2681192T3 (en) 2018-04-16
KR20140009432A (ko) 2014-01-22
JP6022485B2 (ja) 2016-11-09
EA032802B1 (ru) 2019-07-31
NO2681192T3 (https=) 2018-05-26
IL228023A (en) 2017-04-30
TW201247660A (en) 2012-12-01
TWI597279B (zh) 2017-09-01
CA2828509A1 (en) 2012-09-07
MX347348B (es) 2017-04-17
MY163214A (en) 2017-08-30
EA201691331A1 (ru) 2017-01-30
BR112013021882A2 (pt) 2016-07-19
EP2681192B1 (en) 2017-12-27
US20170240509A1 (en) 2017-08-24
EP2681192A1 (en) 2014-01-08
MX2013010132A (es) 2013-10-30
ZA201306174B (en) 2014-05-28
ES2663717T3 (es) 2018-04-16
CN106083840B (zh) 2020-01-03
CN103402982B (zh) 2016-07-13
AR123584A2 (es) 2022-12-21
PT2681192T (pt) 2018-04-02
NZ614173A (en) 2015-04-24
US20170355677A1 (en) 2017-12-14
MA34982B1 (fr) 2014-03-01
EA201892052A1 (ru) 2019-02-28
SI2681192T1 (en) 2018-04-30
UA112539C2 (uk) 2016-09-26
US20130331579A1 (en) 2013-12-12
MX351740B (es) 2017-10-26
CN103402982A (zh) 2013-11-20
AU2012222346B2 (en) 2015-05-07
ECSP13012914A (es) 2013-11-29
SG192793A1 (en) 2013-09-30
US9650373B2 (en) 2017-05-16
GT201300211A (es) 2014-12-30
AU2012222346A1 (en) 2013-08-29
PL2681192T3 (pl) 2018-06-29
TW201722916A (zh) 2017-07-01
US10059670B2 (en) 2018-08-28
AR088714A1 (es) 2014-07-02
TN2013000354A1 (en) 2015-01-20
EA201391267A1 (ru) 2014-01-30
WO2012117071A1 (en) 2012-09-07
CL2013002521A1 (es) 2014-02-14
EA201792068A2 (ru) 2018-01-31
TWI607994B (zh) 2017-12-11
CN106083840A (zh) 2016-11-09
CO6751286A2 (es) 2013-09-16
EA025381B1 (ru) 2016-12-30
IL228023A0 (en) 2013-09-30
EA201792068A3 (ru) 2018-05-31
KR101851421B1 (ko) 2018-04-23
HUE036319T2 (hu) 2018-06-28
JP2014511387A (ja) 2014-05-15
US9776966B2 (en) 2017-10-03

Similar Documents

Publication Publication Date Title
PE20140917A1 (es) Sintesis de derivados de 2-carboxamida-cicloamino-urea
AR088483A1 (es) Proceso para preparar derivados de quinolina
AR089539A1 (es) Metodos de formacion de esteres pinacolicos de acido 4-cloro-2-fluoro-3-sustituido-fenilboronico y sus metodos de uso
BR112015015031A2 (pt) processo de glicoconjugação
PE20141066A1 (es) Compuestos de benzotiazol
AR088564A1 (es) PROCESO PARA LA PREPARACION DE AGONISTAS Y COMPUESTOS INTERMEDIOS DE b3
DOP2010000267A (es) Compuesto heterociclico
CO6640226A2 (es) 5-fluoro-1h-pirazolipiridinas sustituidas y su uso
AR095443A1 (es) Heterociclos condensados con acción sobre atr
AR083903A1 (es) Derivados de benzooxazol y benzotiazol sulfonamidas, utiles para tratar trastornos del ritmo cardiaco y cancer, composiciones farmaceuticas que los contienen y metodo para prepararlos
EA201691102A1 (ru) Способ удаления soиз газа при помощи полиольного сложного раствора
ES2653161T3 (es) Procedimiento de preparación de derivados de 3-alquilsulfinilbenzoílo
MX337320B (es) Análogos halogenados de agentes anti-fibroticos.
CL2008000448A1 (es) Procedimiento para la preparacion de un compuesto de fluoroyodoalcano, donde se contacta un compuesto de formula cf3(cf2)n-y, con una fuente de yodo, y la presencia de un catalizador que contiene elementos con la configuracion d1s1 y elementos lantanoides.
UY35332A (es) Derivados de pirrolotriazina como inhibidores de pi3k
MX2019008652A (es) Metodos mejorados para la acilacion del maitansinol.
MX2016000390A (es) Proceso para fabricar haloacetamidas.
AR088358A1 (es) Proceso de obtencion de acidos isoxazolil-metoxi-nicotinicos
EA201391214A1 (ru) Композиции, содержащие алкилалкоксисульфонаты, для производства термостабильных пен
AR092355A1 (es) Fluoruros de fluoropicolinoilo y procesos para su preparacion
AR082593A1 (es) Proceso para la preparacion de pirazoles
AR094954A1 (es) Preparación de 1,3-(diarilo sustituido)-1,2,4-triazoles e intermediarios derivados de ellos
PA8789601A1 (es) Proceso para la preparación de trifluoralquil-fenil sulfonamidas y de sulfonamidas heterocíclicas
EA201401277A1 (ru) Соединения метантиона, обладающие противовирусной активностью
AR084590A1 (es) Composicion de control de plagas de artropodos y metodo de control de plagas de artropodos

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed